Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Shin Nippon Biomedical Laboratories Ltd. has 2 pending office actions in Medical Devices & Mechanical Engineering. The matters involve 2 distinct examiners and 2 distinct art units, indicating separate examination channels.
MURPHY, VICTORIA is the busiest examiner, with 1 pending matter. Counsel should prepare examiner-specific responses while preserving a consistent portfolio position on claim scope.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MURPHY, VICTORIA | 1 | 62.0% | +46.3% |
| MAEWALL, SNIGDHA | 1 | 58.8% | +10.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18807599 | INTRANASAL DELIVERY DEVICES | MURPHY, VICTORIA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18807599 | INTRANASAL DELIVERY DEVICES | MURPHY, VICTORIA | — |
| 18832910 | ADJUVANT COMPOSITION AND VACCINE COMPOSITION | MAEWALL, SNIGDHA | — |
| Art Unit | Apps |
|---|---|
| 3785 | 1 |
| 1612 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18807599 | INTRANASAL DELIVERY DEVICES | MURPHY, VICTORIA | 3785 | §103§112 | Non-Final OA | — | Pending | Aug 16, 2024 |
| 18832910 | ADJUVANT COMPOSITION AND VACCINE COMPOSITION | MAEWALL, SNIGDHA | 1612 | §103 | Non-Final OA | — | Pending | Jul 24, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialShin Nippon Biomedical Laboratories Ltd. has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Victoria Murphy has the most, with 1 of Shin Nippon Biomedical Laboratories Ltd.'s pending office actions.
Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.
